Table 1.
General advantages and disadvantages of diagnostic platforms broadly available at present for mollusc pathogens.
assay | advantages | disadvantages |
---|---|---|
gross pathology | allows rapid preliminary assessment in systems where specific gross signs are commonly associated with infection (e.g. mikrocytosis in C. gigas, Brown Ring Disease in R. philippinarum) | few pathogens are associated with relatively unambiguous gross signs of disease |
paraffin histopathology | provides excellent perspective on animal health; allows detection of multiple infections and emerging disease events; technology widely available | slow; requires specialized expertise; can be insensitive for detection of small pathogens (e.g. Bonamia); not suitable for viruses and bacteria |
cytology, tissue imprints | rapid and inexpensive; useful for specific evaluation of haemolymph and haemocytes for Bonamia, of digestive gland imprints for Marteilia | not considered effective for detection of Perkinsus or Haplosporidium parasites; not useful for bacteria, viruses |
Ray's fluid thioglycollate method | rapid and inexpensive; useful for specific evaluation of tissue samples for most Perkinsus parasites; can be quantitative | only specific to Perkinsus species |
transmission electron microscopy | allows ultrastructural description; suitable for distinguishing parasites belonging to different genera (e.g. Bonamia from Mikrocytos) and sometimes congeneric species, identifying and characterizing viral infections | expensive, slow; requires specialized expertise and technology that is not universally available; focus on very small tissue areas could result in pathogens being missed |
PCR, conventional | relatively rapid; required skills common in students of biology; technology widely available; can be more sensitive for detection of small pathogens that are difficult to visualize microscopically; specificity can be ‘tuned’ to be broad or narrow | provides indirect and imperfect perspective on animal health; positive results only indicate presence of pathogen DNA, not necessarily viable pathogen or actual infection; requires substantial background knowledge of the genetics of targeted (and ideally, related) pathogens |
PCR, quantitative | same as conventional PCR, but with added advantages of pathogen quantitation, greater speed and likely sensitivity; with validation quantitation may allow stronger inferences about actual infection than are possible with conventional PCR | Same as conventional PCR; platform more expensive, less widely available than for conventional PCR and requires greater expertise for proper interpretation; copy number of target imperfectly correlated with infection intensity |
ISH | best single method for linking a DNA sequence to pathogen observed in tissue sections; as with PCR, sensitivity can be tuned; requires histopathology but more sensitive than conventional histopathology for detection of small cryptic pathogens | (very) slow, very specialized |
DNA sequencing | constitutes the definitive identification of pathogen DNA sequences | same as quantitative PCR; requires PCR amplification first, which is not always straightforward for detection or characterization of new pathogens |
next-generation sequencing | allows rapid profiling of pathogen diversity | expensive, with technology not universally available; requires substantial bioinformatics expertise and resources; as for PCR, positive results not clearly indicative of actual infection |